Polen Capital Repligen Corp Transaction History
Polen Capital Management LLC
- $39.9 Billion
- Q2 2024
A detailed history of Polen Capital (Polen Capital Management LLC) transactions in Repligen Corp stock. As of the latest transaction made, Polen Capital Management LLC holds 14,572 shares of RGEN stock, worth $2.03 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,572Holding current value
$2.03 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RGEN
# of Institutions
494Shares Held
53.8MCall Options Held
420KPut Options Held
85.3K-
Black Rock Inc. New York, NY7.57MShares$1.06 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.07MShares$707 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.61MShares$643 Million0.07% of portfolio
-
State Street Corp Boston, MA1.74MShares$242 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA1.42MShares$198 Million0.55% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $7.74B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....